Tenuigenin down-regulates the release of nitric oxide, matrix metalloproteinase-9 and cytokines from lipopolysaccharide-stimulated microglia

Neuroscience Letters

Volumn 650, Issue , 2017, Pages 82-88

  Lu, Li ^a   Li, Xiaorong ^a   Xu, Pingxiang ^a   Zheng, Yan ^a   Wang, Xiaomin ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

Cytokine; Matrix metalloproteinase 9; Microglia; Nitric oxide; Tenuigenin

Indexed keywords

BETA ACTIN; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MINOCYCLINE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRITE; PLANT EXTRACT; TENUIGENIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE; HERBACEOUS AGENT; MMP9 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ELECTRON SPIN RESONANCE; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; POLYGALA TENUIFOLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; DRUGS, CHINESE HERBAL; INFLAMMATION; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; MICROGLIA; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85018596368     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2017.04.001     Document Type: Article

References (18)

1. [1] Jesky, R., Chen, H., The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells. BMC Complement Altern. Med., 16, 2016, 26.
2. [2] Li, X., Zhao, Y., Liu, P., Zhu, X., Chen, M., Wang, H., Lu, D., Qi, R., Senegenin inhibits hypoxia/reoxygenation-induced neuronal apoptosis by upregulating RhoGDIα. Mol. Neurobiol. 52 (2015), 1561–1571.
3. [3] Liang, Z., Shi, F., Wang, Y., Lu, L., Zhang, Z., Wang, X., Wang, X., Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neurosci. Lett. 497 (2011), 104–109.
4. [4] Ransohoff, R.M., How neuroinflammation contributes to neurodegeneration. Science 353 (2016), 777–783.
5. [5] Balez, R., Ooi, L., Getting to NO alzheimer's disease: neuroprotection versus neurotoxicity mediated by nitric oxide. Oxid. Med. Cell Longev. 2016 (2016), 1–8.
6. [6] Vandooren, J., Van Damme, J., Opdenakker, G., On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation. Prog. Brain Res. 214 (2014), 193–206.
7. [7] Giulian, D., Baker, T.J., Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6 (1986), 2163–2178.
8. [8] Kleiner, D.E., Stetler-Stevenson, W.G., Quantitative zymography: detection of pictogram quantities of gelatinases. Anal. Biochem. 218 (1994), 325–329.
9. [9] Garrido-Mesa, N., Zarzuelo, A., Gálvez, J., Minocycline: far beyond an antibiotic. Br. J. Pharmacol. 169 (2013), 337–352.
10. [10] Huang, J.N., Wang, C.Y., Wang, X.L., Wu, B.Z., Gu, X.Y., Liu, W.X., Gong, L.W., Xiao, P., Li, C.H., Tenuigenin treatment improves behavioral Y-maze learning by enhancing synaptic plasticity in mice. Behav. Brain Res. 246 (2013), 111–115.
11. [11] Zhou, J.X., Zhang, H.B., Huang, Y., He, Y., Zheng, Y., Anderson, J.P., Gai, W.P., Liang, Z.G., Wang, Y., Ren, X.M., Wang, Q., Gong, X.L., Yang, J., Wang, X., Halliday, G., Wang, X.M., Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3. CNS Neurosci. Ther. 19 (2013), 688–694.
12. [12] Yuan, H.L., Li, B., Xu, J., Wang, Y., He, Y., Zheng, Y., Wang, X.M., Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. CNS Neurosci. Ther. 18 (2012), 584–590.
13. [13] Lv, H., Ren, W., Zheng, Y., Wang, L., Lu, G., Yi, P., Ci, X., Tenuigenin exhibits anti-inflammatory activity via inhibiting MAPK and NF-κB and inducing Nrf2/HO-1 signaling in macrophages. Food Funct. 7 (2016), 355–363.
14. [14] Piedagnel, R., Murphy, G., Ronco, P.M., Lelongt, B., Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T arginine vasopressin, and epidermal growth factor. J. Biol. Chem. 274 (1999), 1614–1620.
15. [15] Surgucheva, I., Chidambaram, K., Willoughby, D.A., Surguchov, A., Matrix metalloproteinase 9 expression: new regulatory elements. J. Ocul. Biol. Dis. Inform. 3 (2010), 41–52.
16. [16] Lv, H., Zhu, C., Liao, Y., Gao, Y., Lu, G., Zhong, W., Zheng, Y., Chen, W., Ci, X., Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways. Respir, Physiol, Neurobiol. 216 (2015), 43–51.
17. [17] Fu, H., Hu, Z., Di, X., Zhang, Q., Zhou, R., Du, H., Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway. Eur. J. Pharmacol. 791 (2016), 229–234.
18. [18] Wang, C., Zeng, L., Zhang, T., Liu, J., Wang, W., Tenuigenin prevents IL-1β-induced inflammation in human osteoarthritis chondrocytes by suppressing PI3 K/AKT/NF-κB signaling pathway. Inflammation 39 (2016), 807–812.